| 000 | 01574 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250518081216.0 | ||
| 264 | 0 | _c20201106 | |
| 008 | 202011s 0 0 eng d | ||
| 022 | _a1791-3004 | ||
| 024 | 7 |
_a10.3892/mmr.2019.10835 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWang, Xiaopeng | |
| 245 | 0 | 0 |
_aNeuroprotective effect of CPCGI on Alzheimer's disease and its mechanism. _h[electronic resource] |
| 260 |
_bMolecular medicine reports _c01 2020 |
||
| 300 |
_a115-122 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAlzheimer Disease _xdrug therapy |
| 650 | 0 | 4 |
_aAmyloid beta-Peptides _xmetabolism |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 | _aBehavior Rating Scale |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 |
_aInterleukin-1beta _xmetabolism |
| 650 | 0 | 4 |
_aMAP Kinase Signaling System _xdrug effects |
| 650 | 0 | 4 |
_aMalondialdehyde _xmetabolism |
| 650 | 0 | 4 |
_aNF-kappa B _xmetabolism |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xpharmacology |
| 650 | 0 | 4 |
_aOxidative Stress _xdrug effects |
| 650 | 0 | 4 | _aPC12 Cells |
| 650 | 0 | 4 |
_aPeptide Fragments _xmetabolism |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aReactive Oxygen Species _xmetabolism |
| 650 | 0 | 4 |
_aSuperoxide Dismutase-1 _xmetabolism |
| 650 | 0 | 4 | _aSwine |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xmetabolism |
| 700 | 1 | _aZhao, Jing | |
| 773 | 0 |
_tMolecular medicine reports _gvol. 21 _gno. 1 _gp. 115-122 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3892/mmr.2019.10835 _zAvailable from publisher's website |
| 999 |
_c30520512 _d30520512 |
||